Cargando…
Development and validation of the Cirrhotic Ascites Severity model—A patient‐reported outcome‐based model to predict 1‐year mortality
Ascites formation is a sign of decompensation of cirrhosis and heralds a poor prognosis. The widely used standard binary classification of ascites as diuretic‐responsive or refractory does not cover the spectrum of ascites and has limited prognostic information. We developed the Cirrhotic Ascites Se...
Autores principales: | Gantzel, Rasmus Hvidbjerg, Aagaard, Niels Kristian, Vilstrup, Hendrik, Watson, Hugh, Grønbæk, Henning, Jepsen, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9592767/ https://www.ncbi.nlm.nih.gov/pubmed/35972345 http://dx.doi.org/10.1002/hep4.2065 |
Ejemplares similares
-
Effects and safety of natriuretic peptides as treatment of cirrhotic ascites: A systematic review and meta-analysis
por: Gantzel, Rasmus Hvidbjerg, et al.
Publicado: (2022) -
Diabetes does not increase infection risk or mortality following an infection in patients with cirrhosis and ascites
por: Bossen, Lars, et al.
Publicado: (2019) -
Macrophage Activation Markers, CD163 and CD206, in Acute-on-Chronic Liver Failure
por: Nielsen, Marlene Christina, et al.
Publicado: (2020) -
Non-Selective Beta-Blockers and Risk of Sepsis in Patients with Cirrhosis and Ascites: Results from a Large Observational Study
por: Jensen, Morten Daniel, et al.
Publicado: (2023) -
Macrophage Activation Markers, Soluble CD163 and Mannose Receptor, in Liver Fibrosis
por: Gantzel, Rasmus Hvidbjerg, et al.
Publicado: (2021)